Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$191.17 - $325.63 $15.4 Million - $26.3 Million
-80,747 Reduced 70.53%
33,744 $11 Million
Q4 2023

Feb 14, 2024

BUY
$160.99 - $215.69 $15 Million - $20.1 Million
93,015 Added 433.11%
114,491 $21.8 Million
Q3 2023

Nov 14, 2023

SELL
$194.33 - $283.97 $10.1 Million - $14.7 Million
-51,723 Reduced 70.66%
21,476 $4.28 Million
Q2 2023

Aug 14, 2023

SELL
$223.05 - $302.68 $17.1 Million - $23.1 Million
-76,478 Reduced 51.1%
73,199 $20.9 Million
Q1 2023

May 15, 2023

BUY
$175.41 - $217.92 $22.3 Million - $27.7 Million
126,988 Added 559.69%
149,677 $32.5 Million
Q4 2022

Feb 14, 2023

SELL
$204.38 - $296.82 $4.59 Million - $6.67 Million
-22,477 Reduced 49.77%
22,689 $4.67 Million
Q3 2022

Nov 14, 2022

SELL
$195.21 - $310.53 $2.91 Million - $4.63 Million
-14,919 Reduced 24.83%
45,166 $12.6 Million
Q2 2022

Aug 16, 2022

BUY
$115.91 - $214.48 $1.68 Million - $3.11 Million
14,517 Added 31.86%
60,085 $11.5 Million
Q1 2022

May 17, 2022

BUY
$127.96 - $207.36 $2.65 Million - $4.3 Million
20,724 Added 83.42%
45,568 $9.45 Million
Q4 2021

Feb 15, 2022

BUY
$165.13 - $241.83 $3.71 Million - $5.44 Million
22,479 Added 950.49%
24,844 $4.43 Million
Q3 2021

Nov 16, 2021

SELL
$163.99 - $235.57 $1.12 Million - $1.6 Million
-6,803 Reduced 74.2%
2,365 $487,000
Q2 2021

Aug 16, 2021

SELL
$131.45 - $201.49 $1.01 Million - $1.55 Million
-7,691 Reduced 45.62%
9,168 $1.74 Million
Q1 2021

May 18, 2021

BUY
$92.73 - $142.05 $1.01 Million - $1.55 Million
10,925 Added 184.11%
16,859 $2.2 Million
Q4 2020

Feb 17, 2021

BUY
$67.44 - $103.72 $43,161 - $66,380
640 Added 12.09%
5,934 $615,000
Q2 2020

Aug 17, 2020

BUY
$27.25 - $47.53 $144,261 - $251,623
5,294 New
5,294 $250,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.